Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siu Wa Tang

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Expert Opinion on Pharmacotherapy|March 19, 2008
ParoxetineSiu Wa Tang, Daiga Helmeste
International Clinical Psychopharmacology|April 24, 2020
Hallucinations: diagnosis, neurobiology and clinical managementSiu Wa Tang, Wayne Hans Tang
The International Journal of Neuropsychopharmacology|July 30, 2019
Opportunities in Novel Psychotropic Drug Design from Natural CompoundsSiu Wa Tang, Wayne H Tang
Acta Neuropsychiatrica|April 30, 2021
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammationSiu Wa Tang, Daiga Helmeste, Brian Leonard
International Clinical Psychopharmacology|December 1, 2016
Patients on psychotropic medications and herbal supplement combinations: clinical considerationsSiu Wa Tang, Wayne Tang, Brian E Leonard
Restorative Neurology and Neuroscience|May 3, 2007
Corticosteroid decreases subventricular zone cell proliferation, which could be reversed by paroxetineWui-Man Lau, Guang Qiu, Daiga M Helmeste, et al.
Acta Neuropsychiatrica|December 27, 2021
Treatment-induced mood switching in affective disordersSiu Wa Tang, Wayne H Tang, Brian E Leonard
Acta Neuropsychiatrica|February 11, 2022
Long COVID, neuropsychiatric disorders, psychotropics, present and futureSiu Wa Tang, Brian E Leonard, Daiga Maret Helmeste
Acta Neuropsychiatrica|March 2, 2023
COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brainSiu Wa Tang, Daiga Maret Helmeste, Brian E Leonard
Psychiatry and Clinical Neurosciences|October 16, 2004
Forecasting the number of inpatients with schizophreniaToshiyuki Someya, Yuji Suzuki, Pak C Sham, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Expert Opinion on Pharmacotherapy|March 19, 2008
ParoxetineSiu Wa Tang, Daiga Helmeste
International Clinical Psychopharmacology|April 24, 2020
Hallucinations: diagnosis, neurobiology and clinical managementSiu Wa Tang, Wayne Hans Tang
The International Journal of Neuropsychopharmacology|July 30, 2019
Opportunities in Novel Psychotropic Drug Design from Natural CompoundsSiu Wa Tang, Wayne H Tang
Acta Neuropsychiatrica|April 30, 2021
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammationSiu Wa Tang, Daiga Helmeste, Brian Leonard
International Clinical Psychopharmacology|December 1, 2016
Patients on psychotropic medications and herbal supplement combinations: clinical considerationsSiu Wa Tang, Wayne Tang, Brian E Leonard
Restorative Neurology and Neuroscience|May 3, 2007
Corticosteroid decreases subventricular zone cell proliferation, which could be reversed by paroxetineWui-Man Lau, Guang Qiu, Daiga M Helmeste, et al.
Acta Neuropsychiatrica|December 27, 2021
Treatment-induced mood switching in affective disordersSiu Wa Tang, Wayne H Tang, Brian E Leonard
Acta Neuropsychiatrica|February 11, 2022
Long COVID, neuropsychiatric disorders, psychotropics, present and futureSiu Wa Tang, Brian E Leonard, Daiga Maret Helmeste
Acta Neuropsychiatrica|March 2, 2023
COVID-19 as a polymorphic inflammatory spectrum of diseases: a review with focus on the brainSiu Wa Tang, Daiga Maret Helmeste, Brian E Leonard
Psychiatry and Clinical Neurosciences|October 16, 2004
Forecasting the number of inpatients with schizophreniaToshiyuki Someya, Yuji Suzuki, Pak C Sham, et al.
Pageof 3